Principal investigator: Daniel Simon
In the Organic Bioelectronics (OBE) group, we harness the unique properties of organic electronic materials to fuse biology and technology—bridging the “languages” of ions and molecules with that of electrons. We address critical challenges in accurately interfacing with biochemical and physiological signals, overcoming barriers to targeted therapies and personalized medicine. Our mission is to pioneer minimally invasive, high-precision devices and technologies that integrate naturally with living systems.
As trailblazers in iontronic technologies and in situ bioelectronics, we develop transformative solutions for drug delivery, neuromodulation, biosensing, and beyond. By building on our successes—such as self-organizing in vivo electrodes and on-demand chemical delivery platforms—we aim to shape next-generation approaches for treating complex disorders, from the central and enteric nervous systems to difficult-to-treat cancers. Our interdisciplinary, curiosity-driven culture unites expertise in materials science, chemistry, biology, and engineering, inspiring creative ideas that blur the borders between living tissue and technology. Ultimately, we strive to translate breakthroughs in organic bioelectronics into tangible, life-changing benefits for individuals and society.
